Pulsed Field Ablation (PFA) Therapy

DEVICE2 trials

Sponsors

Biosense Webster, Inc., Insight Medtech Co., Ltd.

Conditions

Arrhythmias, CardiacAtrial FibrillationParoxysmal Atrial Fibrillation

Unknown Phase

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE)

CompletedNCT04524364

Biosense Webster, Inc.Atrial Fibrillation

Start: 2020-08-23End: 2023-05-09Updated: 2025-05-25

InsightPFA Trial of the LotosPFA Catheter

CompletedNCT06014996

Insight Medtech Co., Ltd.Arrhythmias, Cardiac, Paroxysmal Atrial Fibrillation

Start: 2023-09-04End: 2025-07-03Updated: 2025-08-17

Related Papers

Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation: InsightPFA Trial.

2025-12-011 citations

Rationale and Design of the InsightPFA Trial: A Prospective, Multicenter, Randomized Controlled Trial of the Irreversible Electroporation‐Based Pulsed Field Ablation Versus Radiofrequency Ablation in Chinese Patients With Symptomatic Paroxysmal Atrial Fibrillation

Journal of Cardiovascular Electrophysiology2025-01-241 citations

Predictors of Success for Pulmonary Vein Isolation With Pulsed-field Ablation Using a Variable-loop Catheter With 3D Mapping Integration: Complete 12-month Outcomes From inspIRE

Circulation Arrhythmia and Electrophysiology2024-04-2433 citations

Paroxysmal Atrial Fibrillation Ablation Using a Novel Variable-Loop Biphasic Pulsed Field Ablation Catheter Integrated With a 3-Dimensional Mapping System: 1-Year Outcomes of the Multicenter inspIRE Study

Circulation Arrhythmia and Electrophysiology2023-02-03201 citations